===GET READY FOR A FACE-RIPPING RALLY STARTING TUES===
Lots of excitement in the HF community as it appears GBA has nailed the next rotation.
In keeping with that thought.
Our next thread will be primarily AI based. We will use the names already bought and shift them over...
No doubt a major player in AI is Mobileye. This company has been around forever and merged with somebody and then came back public. It is very well thought of in the HF world....
It ticked me a bit that they bought MBLY and not my SUMO BUT the concept has been accepted...
2023 THE YEAR OF AI-!
Mobileye initiated with an Overweight at JPMorgan 07:11 MBLY JPMorgan analyst Samik Chatterjee initiated coverage of Mobileye with an Overweight rating and $50 price target. The company is well positioned to deliver a "secure revenue and earnings ramp" on account of a ramp in advanced driver-assistance system revenue, Chatterjee tells investors in a research note. The analyst forecasts 38% annual revenue growth and a similar earnings trajectory as Mobileye "increasingly moves from being a camera-based ADAS supplier to a supplier of platforms for Enhanced ADAS and Autonomous Vehicles."
Mirati Therapeutics price target raised to $87 from $84 at Piper Sandler 